Genocea Biosciences Inc (GNCA) Jumps 24.58% on February 12

Equities Staff |

Genocea Biosciences Inc (GNCA) was among the biggest gainers on the Russell 2000 for Friday February 12 as the stock popped 24.58% to $3.75, representing a gain of $0.74 per share. Some 342,162 shares traded hands on 1,544 trades, compared with an average daily volume of 304,277 shares out of a total float of 28.12 million. The stock opened at $3.07 and traded with an intraday range of $3.85 to $3.07.

After today's gains, Genocea Biosciences Inc reached a market cap of $105.43 million. Genocea Biosciences Inc has had a trading range between $16.18 and $2.56 over the last year, and it had a 50-day SMA of $4.69 and a 200-day SMA of $8.84.

Genocea Biosciences Inc is a clinical stage biopharmaceutical company that discovers and develops novel vaccines to address infectious diseases for which no vaccine or vaccines with limited effectiveness exist today.

Genocea Biosciences Inc is based out of Cambridge, MA and has some 57 employees. Its CEO is William D. Clark.

For a complete fundamental analysis analysis of Genocea Biosciences Inc, check out’s Stock Valuation Analysis report for GNCA. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

MGX Minerals Inc.

MGX Minerals is a diversified Canadian mining company listed on the Canadian Securities Exchange. MGX is engaged in the acquisition and development of industrial mineral deposits in western Canada that…

Private Markets


Our mission is to be the best place for people who care about music to create and discover thoughtfully curated playlists. In essence, 8tracks is a platform for online mixtapes.

Ozobot by Evollve Inc

Ozobot is a world leader in compact super intelligent robots that entertain and educate through fun interactive gaming.